ciprofloxacin has been researched along with Sexually Transmitted Diseases in 23 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Sexually Transmitted Diseases: Diseases due to or propagated by sexual contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin may be considered as first-line treatment for a number of infections in which gram-negative pathogens are proven or strongly suspected, including complicated urinary tract infections, bacterial prostatitis, bacterial diarrhea, selected bone and joint infections, malignant otitis externa, bronchopulmonary infections in patients with cystic fibrosis and selected pneumonia cases." | 3.69 | Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society. ( Louie, TJ, 1994) |
| "Testing the effects of STD control on AIDS prevention is feasible in this Ugandan setting." | 2.69 | A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. ( Berkley, S; Brookmeyer, R; Gray, RH; Kelly, R; Kiwanuka, N; Li, C; Lutalo, T; McNairn, D; Nalugoda, F; Paxton, L; Quinn, TC; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ, 1998) |
| "Gonorrhea, trichomoniasis, chlamydiosis and Ureaplasma infection were detected in 60, 31." | 2.67 | [Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases]. ( Bakalova, LA; Bednova, VN; Bugrov, AV; Kisina, VI; Navolotskaia, TI; Vakhnina, TE, 1992) |
| "Epididymo-orchitis is a common urological condition in men of all ages, causing a unilateral or bilateral swelling of the epididymis and/or testis." | 2.58 | Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones. ( Cullen, I; Daly, P; Doyle, M; Ryan, L, 2018) |
| "In high-income countries, shigellosis is mainly found in travellers to high-risk regions or in men who have sex with men (MSM)." | 1.62 | Circulation of multi-drug-resistant Shigella sonnei and Shigella flexneri among men who have sex with men in Barcelona, Spain, 2015-2019. ( Alberny, M; Armas, M; Barberà, MJ; Cornejo-Sánchez, T; Espinal, P; Fàbrega, A; González-López, JJ; Goterris, L; Larrosa, MN; Martín-González, H; Mir-Cros, A; Moreno-Mingorance, A; Pumarola, T; Raventós, A; Rodriguez, V; Serra-Pladevall, J; Viñado, B, 2021) |
| "Sexually transmitted infections (STIs), including infections with Neisseria gonorrhoeae (GC), are highly incident in Greenland." | 1.42 | Rapid change in the ciprofloxacin resistance pattern among Neisseria gonorrhoeae strains in Nuuk, Greenland: time to reconsider preventive and treatment strategies. ( Bjorn-Mortensen, K; Jensen, JS; Mulvad, G; Pedersen, ML; Poulsen, P; Rolskov, AS, 2015) |
| "Bacterial vaginosis was present in 32% of the women screened, Chlamydia trachomatis was identified in 8%, none tested positive for Neisseria gonorrhoeae." | 1.32 | Should we offer antibiotic prophylaxis post sexual assault? ( Forster, GE; Gibb, AM; McManus, T, 2003) |
| "Ciprofloxacin was the most commonly used antibiotic." | 1.31 | Would you get your Gonorrhoea treated in the north of England? ( Elawad, BB; White, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 9 (39.13) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Moreno-Mingorance, A | 1 |
| Espinal, P | 1 |
| Rodriguez, V | 1 |
| Goterris, L | 1 |
| Fàbrega, A | 1 |
| Serra-Pladevall, J | 1 |
| Barberà, MJ | 1 |
| Alberny, M | 1 |
| Martín-González, H | 1 |
| Cornejo-Sánchez, T | 1 |
| Armas, M | 1 |
| Mir-Cros, A | 1 |
| Raventós, A | 1 |
| Viñado, B | 1 |
| Pumarola, T | 1 |
| Larrosa, MN | 1 |
| González-López, JJ | 1 |
| Ryan, L | 1 |
| Daly, P | 1 |
| Cullen, I | 1 |
| Doyle, M | 1 |
| Ingle, DJ | 1 |
| Easton, M | 1 |
| Valcanis, M | 1 |
| Seemann, T | 1 |
| Kwong, JC | 1 |
| Stephens, N | 1 |
| Carter, GP | 1 |
| Gonçalves da Silva, A | 1 |
| Adamopoulos, J | 1 |
| Baines, SL | 1 |
| Holt, KE | 1 |
| Chow, EPF | 1 |
| Fairley, CK | 1 |
| Chen, MY | 1 |
| Kirk, MD | 1 |
| Howden, BP | 1 |
| Williamson, DA | 1 |
| Rolskov, AS | 1 |
| Bjorn-Mortensen, K | 1 |
| Mulvad, G | 1 |
| Poulsen, P | 1 |
| Jensen, JS | 1 |
| Pedersen, ML | 1 |
| Dang, NT | 1 |
| Turner, MS | 1 |
| Coombes, AG | 1 |
| Gibb, AM | 1 |
| McManus, T | 1 |
| Forster, GE | 1 |
| Wawer, MJ | 2 |
| Gray, RH | 2 |
| Quinn, T | 1 |
| Louie, TJ | 1 |
| Sewankambo, NK | 1 |
| Serwadda, D | 1 |
| Paxton, L | 1 |
| Berkley, S | 1 |
| McNairn, D | 1 |
| Wabwire-Mangen, F | 1 |
| Li, C | 1 |
| Nalugoda, F | 1 |
| Kiwanuka, N | 1 |
| Lutalo, T | 1 |
| Brookmeyer, R | 1 |
| Kelly, R | 1 |
| Quinn, TC | 1 |
| Klausner, JD | 1 |
| Aplasca, MR | 1 |
| Mesola, VP | 1 |
| Bolan, G | 1 |
| Whittington, WL | 1 |
| Holmes, KK | 1 |
| Matthys, F | 1 |
| Boelaert, M | 1 |
| Ivens, D | 1 |
| Martin, I | 1 |
| Ison, C | 1 |
| Elawad, BB | 1 |
| White, C | 1 |
| Oliphant, CM | 1 |
| Green, GM | 1 |
| Bednova, VN | 1 |
| Bakalova, LA | 1 |
| Bugrov, AV | 1 |
| Navolotskaia, TI | 1 |
| Kisina, VI | 1 |
| Vakhnina, TE | 1 |
| Oduor, DO | 1 |
| Bwayo, JJ | 1 |
| Bhatt, SM | 1 |
| Kwasa, TO | 1 |
| Maitha, GM | 1 |
| Ombette, JO | 1 |
| Waldvogel, FA | 1 |
| Neu, HC | 2 |
| Hartinger, A | 1 |
| Korting, HC | 1 |
| Neubert, U | 1 |
| Blaufuss, H | 1 |
2 reviews available for ciprofloxacin and Sexually Transmitted Diseases
| Article | Year |
|---|---|
Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones.
Topics: Adult; Animals; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; C | 2018 |
Quinolones: a comprehensive review.
Topics: Ciprofloxacin; Drug Interactions; Humans; Male; Prostatitis; Quinolones; Respiratory Tract Diseases; | 2002 |
2 trials available for ciprofloxacin and Sexually Transmitted Diseases
| Article | Year |
|---|---|
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; | 1998 |
[Ofloxacin and ciprofloxacin in the treatment of sexually-transmitted diseases].
Topics: Chlamydia Infections; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female | 1992 |
19 other studies available for ciprofloxacin and Sexually Transmitted Diseases
| Article | Year |
|---|---|
Circulation of multi-drug-resistant Shigella sonnei and Shigella flexneri among men who have sex with men in Barcelona, Spain, 2015-2019.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Disease Susceptibility; Drug Resistance, | 2021 |
Co-circulation of Multidrug-resistant Shigella Among Men Who Have Sex With Men in Australia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Child; Ciprofloxacin; Computational Biology; | 2019 |
Rapid change in the ciprofloxacin resistance pattern among Neisseria gonorrhoeae strains in Nuuk, Greenland: time to reconsider preventive and treatment strategies.
Topics: Adult; Ciprofloxacin; Cohort Studies; Cold Climate; Drug Resistance, Microbial; Female; Gonorrhea; G | 2015 |
Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents.
Topics: Administration, Intravaginal; Anti-Infective Agents; Biocompatible Materials; Ciprofloxacin; Delayed | 2013 |
CDC Discourages STD treatment.
Topics: Anti-Infective Agents; California; Centers for Disease Control and Prevention, U.S.; Ciprofloxacin; | 2002 |
Should we offer antibiotic prophylaxis post sexual assault?
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Chlamydia t | 2003 |
AIDS intervention in Uganda.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cipr | 1995 |
Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
Topics: Administration, Oral; Ciprofloxacin; Diarrhea; Gram-Negative Bacterial Infections; Humans; Respirato | 1994 |
Correlates of gonococcal infection and of antimicrobial-resistant Neisseria gonorrhoeae among female sex workers, Republic of the Philippines, 1996-1997.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Condoms; Drug Resistance, Microbial; Female; Gonorrhea; | 1999 |
Preventing HIV-1: lessons from Mwanza and Rakai.
Topics: Adolescent; Adult; Ciprofloxacin; Drug Costs; Ethics, Medical; HIV Infections; HIV-1; Humans; Middle | 1999 |
National guideline for the management of epididymo-orchitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Ceftriaxone; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Epididymitis; | 1999 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; | 1999 |
Neisseria gonorrhoeae in a London sexually transmitted infection clinic not fully sensitive to quinolones: are isolates imported and how effective is ciprofloxacin as a first-line therapy?
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Community Health Centers; Drug Resist | 2000 |
Would you get your Gonorrhoea treated in the north of England?
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; England; Female; Gonorrhea; Guideline Adher | 2001 |
Multiple sexually acquired diseases occurring concurrently in an HIV positive man: case report, diagnosis and management.
Topics: Adult; Anti-Infective Agents; Chancroid; Ciprofloxacin; Condylomata Acuminata; Gonorrhea; HIV Seropo | 1992 |
Clinical role of the quinolones today and in the future.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clinical Protocols; Forecasting; Humans; | 1989 |
Clinical use of the quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enoxacin; Gastrointestinal Diseases; Humans; Naphthy | 1987 |
[In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Topics: Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Female | 1988 |
Ciprofloxacin: an overview and prospective appraisal.
Topics: Administration, Oral; Animals; Bacterial Infections; Ciprofloxacin; Cystic Fibrosis; Disease Models, | 1987 |